Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour

go back to reference H. Dimaras, T.W. Corson, D. Cobrinik, A. White, J. Zhao, F.L. Munier, D.H. Abramson, C.L. Shields, G.L. Chantada, F. Njuguna, B.L. Gallie, Retinoblastoma. Nat. Rev. Dis. Primers. 1, 15021 (2015)PubMedPubMedCentralCrossRef H. Dimaras, T.W. Corson, D. Cobrinik, A. White, J. Zhao, F.L. Munier, D.H. Abramson, C.L. Shields, G.L. Chantada, F. Njuguna, B.L. Gallie, Retinoblastoma. Nat. Rev. Dis. Primers. 1, 15021 (2015)PubMedPubMedCentralCrossRef

go back to reference T.W. Corson, B.L. Gallie, One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer. 46, 617–634 (2007)PubMedCrossRef T.W. Corson, B.L. Gallie, One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer. 46, 617–634 (2007)PubMedCrossRef

go back to reference D.E. Rushlow, B.M. Mol, J.Y. Kennett, S. Yee, S. Pajovic, B.L. Theriault, N.L. Prigoda-Lee, C. Spencer, H. Dimaras, T.W. Corson, R. Pang, C. Massey, R. Godbout, Z. Jiang, E. Zacksenhaus, K. Paton, A.C. Moll, C. Houdayer, A. Raizis, W. Halliday, W.L. Lam, P.C. Boutros, D. Lohmann, J.C. Dorsman, Gallie. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 14, 327–334 (2013)PubMedCrossRef D.E. Rushlow, B.M. Mol, J.Y. Kennett, S. Yee, S. Pajovic, B.L. Theriault, N.L. Prigoda-Lee, C. Spencer, H. Dimaras, T.W. Corson, R. Pang, C. Massey, R. Godbout, Z. Jiang, E. Zacksenhaus, K. Paton, A.C. Moll, C. Houdayer, A. Raizis, W. Halliday, W.L. Lam, P.C. Boutros, D. Lohmann, J.C. Dorsman, Gallie. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 14, 327–334 (2013)PubMedCrossRef

go back to reference E.A. Price, R. Patel, I. Scheimberg, E. Kotiloglu Karaa, M.S. Sagoo, M.A. Reddy, Onadim. MYCN amplification levels in primary retinoblastoma tumors analyzed by multiple ligation-dependent probe amplification. Ophthalmic Genet. 42, 604–611 (2021)PubMedCrossRef E.A. Price, R. Patel, I. Scheimberg, E. Kotiloglu Karaa, M.S. Sagoo, M.A. Reddy, Onadim. MYCN amplification levels in primary retinoblastoma tumors analyzed by multiple ligation-dependent probe amplification. Ophthalmic Genet. 42, 604–611 (2021)PubMedCrossRef

go back to reference J. Liu, D. Ottaviani, M. Sefta, C. Desbrousses, E. Chapeaublanc, R. Aschero, N. Sirab, F. Lubieniecki, G. Lamas, L. Tonon, C. Dehainault, C. Hua, P. Freneaux, S. Reichman, N. Karboul, A. Biton, L. Mirabal-Ortega, M. Larcher, C. Brulard, S. Arrufat, A. Nicolas, N. Elarouci, T. Popova, F. Nemati, D. Decaudin, D. Gentien, S. Baulande, O. Mariani, F. Dufour, S. Guibert, C. Vallot, L.L. Rouic, A. Matet, L. Desjardins, G. Pascual-Pasto, M. Sunol, J. Catala-Mora, G.C. Llano, J. Couturier, E. Barillot, P. Schaiquevich, M. Gauthier-Villars, D. Stoppa-Lyonnet, L. Golmard, C. Houdayer, H. Brisse, I. Bernard-Pierrot, E. Letouze, A. Viari, S. Saule, X. Sastre-Garau, F. Doz, A.M. Carcaboso, N. Cassoux, C. Pouponnot, O. Goureau, G. Chantada, A. de Reynies, I. Aerts, F. Radvanyi, A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat. Commun. 12, 5578 (2021)ADSPubMedPubMedCentralCrossRef J. Liu, D. Ottaviani, M. Sefta, C. Desbrousses, E. Chapeaublanc, R. Aschero, N. Sirab, F. Lubieniecki, G. Lamas, L. Tonon, C. Dehainault, C. Hua, P. Freneaux, S. Reichman, N. Karboul, A. Biton, L. Mirabal-Ortega, M. Larcher, C. Brulard, S. Arrufat, A. Nicolas, N. Elarouci, T. Popova, F. Nemati, D. Decaudin, D. Gentien, S. Baulande, O. Mariani, F. Dufour, S. Guibert, C. Vallot, L.L. Rouic, A. Matet, L. Desjardins, G. Pascual-Pasto, M. Sunol, J. Catala-Mora, G.C. Llano, J. Couturier, E. Barillot, P. Schaiquevich, M. Gauthier-Villars, D. Stoppa-Lyonnet, L. Golmard, C. Houdayer, H. Brisse, I. Bernard-Pierrot, E. Letouze, A. Viari, S. Saule, X. Sastre-Garau, F. Doz, A.M. Carcaboso, N. Cassoux, C. Pouponnot, O. Goureau, G. Chantada, A. de Reynies, I. Aerts, F. Radvanyi, A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat. Commun. 12, 5578 (2021)ADSPubMedPubMedCentralCrossRef

go back to reference S. Zugbi, D. Ganiewich, A. Bhattacharyya, R. Aschero, D. Ottaviani, C. Sampor, E.G. Cafferata, M. Mena, M. Sgroi, U. Winter, G. Lamas, M. Sunol, M. Daroqui, E. Baialardo, B. Salas, A. Das, A. Fandino, J.H. Francis, F. Lubieniecki, C. Lavarino, R. Garippa, O.L. Podhajcer, D.H. Abramson, F. Radvanyi, G. Chantada, A.S. Llera, P. Schaiquevich, Clinical, genomic, and pharmacological study of MYCN-Amplified RB1 wild-type metastatic retinoblastoma. Cancers 12(9), 2714 (2020)PubMedPubMedCentralCrossRef S. Zugbi, D. Ganiewich, A. Bhattacharyya, R. Aschero, D. Ottaviani, C. Sampor, E.G. Cafferata, M. Mena, M. Sgroi, U. Winter, G. Lamas, M. Sunol, M. Daroqui, E. Baialardo, B. Salas, A. Das, A. Fandino, J.H. Francis, F. Lubieniecki, C. Lavarino, R. Garippa, O.L. Podhajcer, D.H. Abramson, F. Radvanyi, G. Chantada, A.S. Llera, P. Schaiquevich, Clinical, genomic, and pharmacological study of MYCN-Amplified RB1 wild-type metastatic retinoblastoma. Cancers 12(9), 2714 (2020)PubMedPubMedCentralCrossRef

go back to reference M.K.E. Blixt, M. Hellsand, D. Konjusha, H. Zhang, S. Stenfelt, M. Akesson, N. Rafati, T. Tararuk, G. Stalhammar, C. All-Eriksson, H. Ring, Hallbook. MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma. Oncogenesis 11, 34 (2022)PubMedPubMedCentralCrossRef M.K.E. Blixt, M. Hellsand, D. Konjusha, H. Zhang, S. Stenfelt, M. Akesson, N. Rafati, T. Tararuk, G. Stalhammar, C. All-Eriksson, H. Ring, Hallbook. MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma. Oncogenesis 11, 34 (2022)PubMedPubMedCentralCrossRef

go back to reference H.P. Singh, D.W.H. Shayler, G.E. Fernandez, M.E. Thornton, C.M. Craft, B.H. Grubbs, D. Cobrinik, An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma. Proc. Natl. Acad. Sci. U S A 119, e2200721119 (2022)PubMedPubMedCentralCrossRef H.P. Singh, D.W.H. Shayler, G.E. Fernandez, M.E. Thornton, C.M. Craft, B.H. Grubbs, D. Cobrinik, An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma. Proc. Natl. Acad. Sci. U S A 119, e2200721119 (2022)PubMedPubMedCentralCrossRef

go back to reference H. Liu, Y. Zhang, Y.Y. Zhang, Y.P. Li, Z.Q. Hua, C.J. Zhang, K.C. Wu, F. Yu, Y. Zhang, J. Su, Z.B. Jin, Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proc. Natl. Acad. Sci. U S A 117, 33628–33638 (2020)ADSPubMedPubMedCentralCrossRef H. Liu, Y. Zhang, Y.Y. Zhang, Y.P. Li, Z.Q. Hua, C.J. Zhang, K.C. Wu, F. Yu, Y. Zhang, J. Su, Z.B. Jin, Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proc. Natl. Acad. Sci. U S A 117, 33628–33638 (2020)ADSPubMedPubMedCentralCrossRef

go back to reference A. Rozanska, R. Cerna-Chavez, R. Queen, J. Collin, D. Zerti, B. Dorgau, C.S. Beh, T. Davey, J. Coxhead, R. Hussain, J. Al-Aama, D.H. Steel, N. Benvenisty, L. Armstrong, M. Parulekar, M. Lako, pRB-Depleted pluripotent stem cell retinal Organoids recapitulate cell state transitions of Retinoblastoma Development and suggest an important role for pRB in retinal cell differentiation. Stem Cells Transl. Med. 11, 415–433 (2022)PubMedPubMedCentralCrossRef A. Rozanska, R. Cerna-Chavez, R. Queen, J. Collin, D. Zerti, B. Dorgau, C.S. Beh, T. Davey, J. Coxhead, R. Hussain, J. Al-Aama, D.H. Steel, N. Benvenisty, L. Armstrong, M. Parulekar, M. Lako, pRB-Depleted pluripotent stem cell retinal Organoids recapitulate cell state transitions of Retinoblastoma Development and suggest an important role for pRB in retinal cell differentiation. Stem Cells Transl. Med. 11, 415–433 (2022)PubMedPubMedCentralCrossRef

go back to reference X.L. Xu, H.P. Singh, L. Wang, D.L. Qi, B.K. Poulos, D.H. Abramson, S.C. Jhanwar, D. Cobrinik, Rb suppresses human cone-precursor-derived retinoblastoma tumours. Nature. 514, 385–388 (2014)ADSPubMedPubMedCentralCrossRef X.L. Xu, H.P. Singh, L. Wang, D.L. Qi, B.K. Poulos, D.H. Abramson, S.C. Jhanwar, D. Cobrinik, Rb suppresses human cone-precursor-derived retinoblastoma tumours. Nature. 514, 385–388 (2014)ADSPubMedPubMedCentralCrossRef

go back to reference T. Otto, S. Horn, M. Brockmann, U. Eilers, L. Schuttrumpf, N. Popov, A.M. Kenney, J.H. Schulte, R. Beijersbergen, H. Christiansen, B. Berwanger, M. Eilers, Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell. 15, 67–78 (2009)PubMedCrossRef T. Otto, S. Horn, M. Brockmann, U. Eilers, L. Schuttrumpf, N. Popov, A.M. Kenney, J.H. Schulte, R. Beijersbergen, H. Christiansen, B. Berwanger, M. Eilers, Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell. 15, 67–78 (2009)PubMedCrossRef

go back to reference B. Cook, C. Portera-Cailliau, R. Adler, Developmental neuronal death is not a universal phenomenon among cell types in the chick embryo retina. J Comp Neurol 396, 12–19 (1998)PubMedCrossRef B. Cook, C. Portera-Cailliau, R. Adler, Developmental neuronal death is not a universal phenomenon among cell types in the chick embryo retina. J Comp Neurol 396, 12–19 (1998)PubMedCrossRef

go back to reference T. Chavarria, J. Baleriola, R. Mayordomo, F. de Pablo, E.J. de la Rosa, Early neural cell death is an extensive, dynamic process in the embryonic chick and mouse retina. Sci. World J. 2013, 627240 (2013)CrossRef T. Chavarria, J. Baleriola, R. Mayordomo, F. de Pablo, E.J. de la Rosa, Early neural cell death is an extensive, dynamic process in the embryonic chick and mouse retina. Sci. World J. 2013, 627240 (2013)CrossRef

go back to reference X.L. Xu, Y. Fang, T.C. Lee, D. Forrest, C. Gregory-Evans, D. Almeida, A. Liu, S.C. Jhanwar, D.H. Abramson, D. Cobrinik, Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell. 137, 1018–1031 (2009)PubMedPubMedCentralCrossRef X.L. Xu, Y. Fang, T.C. Lee, D. Forrest, C. Gregory-Evans, D. Almeida, A. Liu, S.C. Jhanwar, D.H. Abramson, D. Cobrinik, Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell. 137, 1018–1031 (2009)PubMedPubMedCentralCrossRef

go back to reference S.L. Donovan, J.C. Corbo, Retinal horizontal cells lacking Rb1 sustain persistent DNA damage and survive as polyploid giant cells. Mol. Biol. Cell 23, 4362–4372 (2012)PubMedPubMedCentralCrossRef S.L. Donovan, J.C. Corbo, Retinal horizontal cells lacking Rb1 sustain persistent DNA damage and survive as polyploid giant cells. Mol. Biol. Cell 23, 4362–4372 (2012)PubMedPubMedCentralCrossRef

go back to reference S. Shirazi Fard, M.K.E. Blixt, F. Hallböök, The p53 co-activator Zac1 neither induces cell cycle arrest nor apoptosis in chicken Lim1 horizontal progenitor cells. Cell. Death Discov. 1, e15023 (2015)CrossRef S. Shirazi Fard, M.K.E. Blixt, F. Hallböök, The p53 co-activator Zac1 neither induces cell cycle arrest nor apoptosis in chicken Lim1 horizontal progenitor cells. Cell. Death Discov. 1, e15023 (2015)CrossRef

go back to reference S. Shirazi Fard, M. Jarrin, H. Boije, V. Fillon, C. All-Eriksson, F. Hallbook, Heterogenic final cell cycle by chicken retinal Lim1 horizontal progenitor cells leads to heteroploid cells with a remaining replicated genome. PLoS ONE 8, e59133 (2013)ADSPubMedPubMedCentralCrossRef S. Shirazi Fard, M. Jarrin, H. Boije, V. Fillon, C. All-Eriksson, F. Hallbook, Heterogenic final cell cycle by chicken retinal Lim1 horizontal progenitor cells leads to heteroploid cells with a remaining replicated genome. PLoS ONE 8, e59133 (2013)ADSPubMedPubMedCentralCrossRef

go back to reference S. Shirazi Fard, M. Thyselius, C. All-Ericsson, F. Hallbook, The terminal basal mitosis of chicken retinal Lim1 horizontal cells is not sensitive to cisplatin-induced cell cycle arrest. Cell Cycle 13, 3698–3706 (2014)PubMedPubMedCentralCrossRef S. Shirazi Fard, M. Thyselius, C. All-Ericsson, F. Hallbook, The terminal basal mitosis of chicken retinal Lim1 horizontal cells is not sensitive to cisplatin-induced cell cycle arrest. Cell Cycle 13, 3698–3706 (2014)PubMedPubMedCentralCrossRef

go back to reference D. Chen, I. Livne-bar, J.L. Vanderluit, R.S. Slack, M. Agochiya, R. Bremner, Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5, 539–551 (2004)PubMedCrossRef D. Chen, I. Livne-bar, J.L. Vanderluit, R.S. Slack, M. Agochiya, R. Bremner, Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5, 539–551 (2004)PubMedCrossRef

go back to reference G. Leone, R. Sears, E. Huang, R. Rempel, F. Nuckolls, C.H. Park, P. Giangrande, L. Wu, H.I. Saavedra, S.J. Field, M.A. Thompson, H. Yang, Y. Fujiwara, M.E. Greenberg, S. Orkin, C. Smith, J.R. Nevins, Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell. 8, 105–113 (2001)PubMedCrossRef G. Leone, R. Sears, E. Huang, R. Rempel, F. Nuckolls, C.H. Park, P. Giangrande, L. Wu, H.I. Saavedra, S.J. Field, M.A. Thompson, H. Yang, Y. Fujiwara, M.E. Greenberg, S. Orkin, C. Smith, J.R. Nevins, Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell. 8, 105–113 (2001)PubMedCrossRef

go back to reference K.A. O’Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, J.T. Mendell, c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 435, 839–843 (2005)ADSPubMedCrossRef K.A. O’Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, J.T. Mendell, c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 435, 839–843 (2005)ADSPubMedCrossRef

go back to reference G. Bretones, M.D. Delgado, J. Leon, Myc and cell cycle control. Biochim. Biophys. Acta 1849, 506–516 (2015)PubMedCrossRef G. Bretones, M.D. Delgado, J. Leon, Myc and cell cycle control. Biochim. Biophys. Acta 1849, 506–516 (2015)PubMedCrossRef

go back to reference K.G. Ewens, T.R. Bhatti, K.A. Moran, J. Richards-Yutz, C.L. Shields, R.C. Eagle, A. Ganguly, Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. Cancer Med. 6, 619–630 (2017)PubMedPubMedCentralCrossRef K.G. Ewens, T.R. Bhatti, K.A. Moran, J. Richards-Yutz, C.L. Shields, R.C. Eagle, A. Ganguly, Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. Cancer Med. 6, 619–630 (2017)PubMedPubMedCentralCrossRef

go back to reference V. Hamburger, H. Hamilton, A series of normal stages in the development of the chicken embryo. J. Morphol. 88, 49–92 (1951)PubMedCrossRef V. Hamburger, H. Hamilton, A series of normal stages in the development of the chicken embryo. J. Morphol. 88, 49–92 (1951)PubMedCrossRef

go back to reference B.U.S. Bushnell, BBMap: A Fast, Accurate, Splice-Aware Aligner. OSTI121166 (2014). https://www.osti.gov/servlets/purl/1241166. Accessed March 17 B.U.S. Bushnell, BBMap: A Fast, Accurate, Splice-Aware Aligner. OSTI121166 (2014). https://​www.​osti.​gov/​servlets/​purl/​1241166. Accessed March 17

go back to reference P. Ewels, M. Magnusson, S. Lundin, M. Kaller, MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048 (2016)PubMedPubMedCentralCrossRef P. Ewels, M. Magnusson, S. Lundin, M. Kaller, MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048 (2016)PubMedPubMedCentralCrossRef

go back to reference S. Andrews, F. Krueger, A. Segonds-Pichon, L. Biggins, C. Krueger, J. Montgomery. FastQC: A quality control tool for high throughput sequence data. v.0.11.9. (2019). http://www.bioinformatics.babraham.ac.uk/projects/fastqc/. Accessed Jan 8 S. Andrews, F. Krueger, A. Segonds-Pichon, L. Biggins, C. Krueger, J. Montgomery. FastQC: A quality control tool for high throughput sequence data. v.0.11.9. (2019). http://​www.​bioinformatics.​babraham.​ac.​uk/​projects/​fastqc/​. Accessed Jan 8

go back to reference Y. Liao, G.K. Smyth, W. Shi, FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2013)PubMedCrossRef Y. Liao, G.K. Smyth, W. Shi, FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2013)PubMedCrossRef

go back to reference M.D. Robinson, D.J. McCarthy, G.K. Smyth, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26, 139–140 (2010)PubMedCrossRef M.D. Robinson, D.J. McCarthy, G.K. Smyth, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26, 139–140 (2010)PubMedCrossRef

go back to reference G. Yu, L.G. Wang, Y. Han, Q.Y. He, clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012)PubMedPubMedCentralCrossRef G. Yu, L.G. Wang, Y. Han, Q.Y. He, clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012)PubMedPubMedCentralCrossRef

go back to reference W. Luo, C. Brouwer, Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29, 1830–1831 (2013)PubMedPubMedCentralCrossRef W. Luo, C. Brouwer, Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29, 1830–1831 (2013)PubMedPubMedCentralCrossRef

go back to reference M. Harun-Or-Rashid, N. Lindqvist, F. Hallböök, Transactivation of EGF receptors in chicken muller cells by alpha2A-adrenergic receptors stimulated by brimonidine. Invest. Ophthalmol Vis. Sci. 55, 3385–3394 (2014)PubMedCrossRef M. Harun-Or-Rashid, N. Lindqvist, F. Hallböök, Transactivation of EGF receptors in chicken muller cells by alpha2A-adrenergic receptors stimulated by brimonidine. Invest. Ophthalmol Vis. Sci. 55, 3385–3394 (2014)PubMedCrossRef

go back to reference T.D. Lamb, D.M. Hunt, Evolution of the calcium feedback steps of vertebrate phototransduction. Open Biol. 8, 170232 (2018)PubMedPubMedCentralCrossRef T.D. Lamb, D.M. Hunt, Evolution of the calcium feedback steps of vertebrate phototransduction. Open Biol. 8, 170232 (2018)PubMedPubMedCentralCrossRef

go back to reference K. Yamagata, K. Goto, C.H. Kuo, H. Kondo, N. Miki, Visinin: a novel calcium binding protein expressed in retinal cone cells. Neuron 4, 469–476 (1990)PubMedCrossRef K. Yamagata, K. Goto, C.H. Kuo, H. Kondo, N. Miki, Visinin: a novel calcium binding protein expressed in retinal cone cells. Neuron 4, 469–476 (1990)PubMedCrossRef

go back to reference T.W. Reid, D.M. Albert, A.S. Rabson, P. Russell, J. Craft, E.W. Chu, T.S. Tralka, J.L. Wilcox, Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst. 53, 347–360 (1974)PubMedCrossRef T.W. Reid, D.M. Albert, A.S. Rabson, P. Russell, J. Craft, E.W. Chu, T.S. Tralka, J.L. Wilcox, Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst. 53, 347–360 (1974)PubMedCrossRef

go back to reference S.M. Rubin, Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem. Sci. 38, 12–19 (2013)PubMedCrossRef S.M. Rubin, Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem. Sci. 38, 12–19 (2013)PubMedCrossRef

go back to reference D.O. Morgan, Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261–291 (1997)PubMedCrossRef D.O. Morgan, Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261–291 (1997)PubMedCrossRef

go back to reference A. Rocca, A. Farolfi, S. Bravaccini, A. Schirone, D. Amadori, Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer. Expert Opin. Pharmacother. 15, 407–420 (2014)PubMedCrossRef A. Rocca, A. Farolfi, S. Bravaccini, A. Schirone, D. Amadori, Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer. Expert Opin. Pharmacother. 15, 407–420 (2014)PubMedCrossRef

go back to reference T.D. Lamb, Photoreceptor physiology and evolution: cellular and molecular basis of rod and cone phototransduction. J. Physiol 600, 4585–4601 (2022)PubMedCrossRef T.D. Lamb, Photoreceptor physiology and evolution: cellular and molecular basis of rod and cone phototransduction. J. Physiol 600, 4585–4601 (2022)PubMedCrossRef

go back to reference D. Larhammar, K. Nordstrom, T.A. Larsson, Evolution of vertebrate rod and cone phototransduction genes. Philos. Trans. R Soc. Lond B Biol. Sci. 364, 2867–2880 (2009)PubMedPubMedCentralCrossRef D. Larhammar, K. Nordstrom, T.A. Larsson, Evolution of vertebrate rod and cone phototransduction genes. Philos. Trans. R Soc. Lond B Biol. Sci. 364, 2867–2880 (2009)PubMedPubMedCentralCrossRef

go back to reference W.H. Lee, A.L. Murphree, W.F. Benedict, Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309, 458–460 (1984)ADSPubMedCrossRef W.H. Lee, A.L. Murphree, W.F. Benedict, Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309, 458–460 (1984)ADSPubMedCrossRef

go back to reference J. McEvoy, P. Nagahawatte, D. Finkelstein, J. Richards-Yutz, M. Valentine, J. Ma, C. Mullighan, G. Song, X. Chen, M. Wilson, R. Brennan, S. Pounds, J. Becksfort, R. Huether, C. Lu, R.S. Fulton, L.L. Fulton, X. Hong, D.J. Dooling, K. Ochoa, E.R. Mardis, R.K. Wilson, J. Easton, J. Zhang, J.R. Downing, A. Ganguly, M.A. Dyer, RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget. 5, 438–450 (2014)PubMedPubMedCentralCrossRef J. McEvoy, P. Nagahawatte, D. Finkelstein, J. Richards-Yutz, M. Valentine, J. Ma, C. Mullighan, G. Song, X. Chen, M. Wilson, R. Brennan, S. Pounds, J. Becksfort, R. Huether, C. Lu, R.S. Fulton, L.L. Fulton, X. Hong, D.J. Dooling, K. Ochoa, E.R. Mardis, R.K. Wilson, J. Easton, J. Zhang, J.R. Downing, A. Ganguly, M.A. Dyer, RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget. 5, 438–450 (2014)PubMedPubMedCentralCrossRef

go back to reference S.H. Kim, M. Mitchell, H. Fujii, S. Llanos, G. Peters, Absence of p16INK4a and truncation of ARF tumor suppressors in chickens. Proc. Natl. Acad. Sci. U S A 100, 211–216 (2003)ADSPubMedCrossRef S.H. Kim, M. Mitchell, H. Fujii, S. Llanos, G. Peters, Absence of p16INK4a and truncation of ARF tumor suppressors in chickens. Proc. Natl. Acad. Sci. U S A 100, 211–216 (2003)ADSPubMedCrossRef

go back to reference D. Saengwimol, P. Chittavanich, N. Laosillapacharoen, A. Srimongkol, V. Chaitankar, D. Rojanaporn, R. Aroonroch, B. Suktitipat, C. Saisawang, S. Svasti, S. Hongeng, R. Kaewkhaw, Silencing of the long noncoding RNA MYCNOS1 suppresses activity of MYCN-Amplified Retinoblastoma without RB1 Mutation. Invest. Ophthalmol. Vis. Sci. 61, 8 (2020)PubMedPubMedCentralCrossRef D. Saengwimol, P. Chittavanich, N. Laosillapacharoen, A. Srimongkol, V. Chaitankar, D. Rojanaporn, R. Aroonroch, B. Suktitipat, C. Saisawang, S. Svasti, S. Hongeng, R. Kaewkhaw, Silencing of the long noncoding RNA MYCNOS1 suppresses activity of MYCN-Amplified Retinoblastoma without RB1 Mutation. Invest. Ophthalmol. Vis. Sci. 61, 8 (2020)PubMedPubMedCentralCrossRef

go back to reference Y. Luo, M. He, J. Yang, F. Zhang, J. Chen, X. Wen, J. Fan, X. Fan, P. Chai, R. Jia, A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m(6)A -dependent activation of multiple oncogenes. Sci China Life Sci (2023). https://doi.org/10.1007/s11427-022-2288-4 Y. Luo, M. He, J. Yang, F. Zhang, J. Chen, X. Wen, J. Fan, X. Fan, P. Chai, R. Jia, A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m(6)A -dependent activation of multiple oncogenes. Sci China Life Sci (2023). https://​doi.​org/​10.​1007/​s11427-022-2288-4

go back to reference L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, C. Klein, N. Fotouhi, E.A. Liu, In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 303, 844–848 (2004)ADSPubMedCrossRef L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, C. Klein, N. Fotouhi, E.A. Liu, In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 303, 844–848 (2004)ADSPubMedCrossRef

go back to reference P.G. Komarov, E.A. Komarova, R.V. Kondratov, K. Christov-Tselkov, J.S. Coon, M.V. Chernov, A.V. Gudkov, A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 285, 1733–1737 (1999)PubMedCrossRef P.G. Komarov, E.A. Komarova, R.V. Kondratov, K. Christov-Tselkov, J.S. Coon, M.V. Chernov, A.V. Gudkov, A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 285, 1733–1737 (1999)PubMedCrossRef

go back to reference J. Zhu, M. Singh, G. Selivanova, S. Peuget, Pifithrin-alpha alters p53 post-translational modifications pattern and differentially inhibits p53 target genes. Sci. Rep. 10, 1049 (2020)ADSPubMedPubMedCentralCrossRef J. Zhu, M. Singh, G. Selivanova, S. Peuget, Pifithrin-alpha alters p53 post-translational modifications pattern and differentially inhibits p53 target genes. Sci. Rep. 10, 1049 (2020)ADSPubMedPubMedCentralCrossRef

go back to reference A. di Pietro, R. Koster, W. Boersma-van Eck, W.A. Dam, N.H. Mulder, J.A. Gietema, E.G. de Vries, S. de Jong, Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent. Cell Cycle 11, 4552–4562 (2012)PubMedPubMedCentralCrossRef A. di Pietro, R. Koster, W. Boersma-van Eck, W.A. Dam, N.H. Mulder, J.A. Gietema, E.G. de Vries, S. de Jong, Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent. Cell Cycle 11, 4552–4562 (2012)PubMedPubMedCentralCrossRef

go back to reference Y. Ma, C.A. Kurtyka, S. Boyapalle, S.S. Sung, H. Lawrence, W. Guida, W.D. Cress, A small-molecule E2F inhibitor blocks growth in a melanoma culture model. Cancer Res. 68, 6292–6299 (2008)PubMedPubMedCentralCrossRef Y. Ma, C.A. Kurtyka, S. Boyapalle, S.S. Sung, H. Lawrence, W. Guida, W.D. Cress, A small-molecule E2F inhibitor blocks growth in a melanoma culture model. Cancer Res. 68, 6292–6299 (2008)PubMedPubMedCentralCrossRef

go back to reference J. Yoon, O.V. Grinchuk, R. Tirado-Magallanes, Z.K. Ngian, E.X.Y. Tay, Y.H. Chuah, B.W.L. Lee, J. Feng, K.C. Crasta, C.T. Ong, T. Benoukraf, D.S.T. Ong, E2F and STAT3 provide transcriptional synergy for histone variant H2AZ activation to sustain glioblastoma chromatin accessibility and tumorigenicity. Cell Death Differ. 29, 1379–1394 (2022)PubMedPubMedCentralCrossRef J. Yoon, O.V. Grinchuk, R. Tirado-Magallanes, Z.K. Ngian, E.X.Y. Tay, Y.H. Chuah, B.W.L. Lee, J. Feng, K.C. Crasta, C.T. Ong, T. Benoukraf, D.S.T. Ong, E2F and STAT3 provide transcriptional synergy for histone variant H2AZ activation to sustain glioblastoma chromatin accessibility and tumorigenicity. Cell Death Differ. 29, 1379–1394 (2022)PubMedPubMedCentralCrossRef

go back to reference M. Schwermer, M. Hiber, S. Dreesmann, A. Rieb, J. Theissen, T. Herold, A. Schramm, P. Temming, L. Steenpass, Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines. Exp. Cell Res. 375, 92–99 (2019)PubMedCrossRef M. Schwermer, M. Hiber, S. Dreesmann, A. Rieb, J. Theissen, T. Herold, A. Schramm, P. Temming, L. Steenpass, Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines. Exp. Cell Res. 375, 92–99 (2019)PubMedCrossRef

go back to reference L. Malorni, S. Piazza, Y. Ciani, C. Guarducci, M. Bonechi, C. Biagioni, C.D. Hart, R. Verardo, A. Di Leo, I. Migliaccio, A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer. Oncotarget 7, 68012–68022 (2016)PubMedPubMedCentralCrossRef L. Malorni, S. Piazza, Y. Ciani, C. Guarducci, M. Bonechi, C. Biagioni, C.D. Hart, R. Verardo, A. Di Leo, I. Migliaccio, A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer. Oncotarget 7, 68012–68022 (2016)PubMedPubMedCentralCrossRef

go back to reference B.L. Theriault, H. Dimaras, B.L. Gallie, T.W. Corson, The genomic landscape of retinoblastoma: a review. Clin. Exp. Ophthalmol. 42, 33–52 (2014)PubMedCrossRef B.L. Theriault, H. Dimaras, B.L. Gallie, T.W. Corson, The genomic landscape of retinoblastoma: a review. Clin. Exp. Ophthalmol. 42, 33–52 (2014)PubMedCrossRef

go back to reference N.A. Laurie, C.S. Shih, M.A. Dyer, Targeting MDM2 and MDMX in retinoblastoma. Curr. Cancer Drug Targets 7, 689–695 (2007)PubMedCrossRef N.A. Laurie, C.S. Shih, M.A. Dyer, Targeting MDM2 and MDMX in retinoblastoma. Curr. Cancer Drug Targets 7, 689–695 (2007)PubMedCrossRef

go back to reference H.N. Tran, H.P. Singh, W. Guo, L. Cambier, L. Riggan, G.M. Shackleford, M.E. Thornton, B.H. Grubbs, A. Erdreich-Epstein, D.L. Qi, D. Cobrinik, Reciprocal induction of MDM2 and MYCN in neural and neuroendocrine cancers. Front. Oncol. 10, 563156 (2020)PubMedPubMedCentralCrossRef H.N. Tran, H.P. Singh, W. Guo, L. Cambier, L. Riggan, G.M. Shackleford, M.E. Thornton, B.H. Grubbs, A. Erdreich-Epstein, D.L. Qi, D. Cobrinik, Reciprocal induction of MDM2 and MYCN in neural and neuroendocrine cancers. Front. Oncol. 10, 563156 (2020)PubMedPubMedCentralCrossRef

go back to reference D.L. Qi, D. Cobrinik, MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene 36, 1760–1769 (2017)PubMedCrossRef D.L. Qi, D. Cobrinik, MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene 36, 1760–1769 (2017)PubMedCrossRef

go back to reference P.F. Sullivan, J.R.S. Meadows, S. Gazal, B.N. Phan, X. Li, D.P. Genereux, M.X. Dong, M. Bianchi, G. Andrews, S. Sakthikumar, J. Nordin, A. Roy, M.J. Christmas, V.D. Marinescu, C. Wang, O. Wallerman, J. Xue, S. Yao, Q. Sun, J. Szatkiewicz, J. Wen, L.M. Huckins, A. Lawler, K.C. Keough, Z. Zheng, J. Zeng, N.R. Wray, Y. Li, J. Johnson, J. Chen, s. Zoonomia Consortium section, B. Paten, S.K. Reilly, G.M. Hughes, Z. Weng, K.S. Pollard, A.R. Pfenning, K. Forsberg-Nilsson, E.K. Karlsson, K. Lindblad-Toh, G. Andrews, J.C. Armstrong, M. Bianchi, B.W. Birren, K.R. Bredemeyer, A.M. Breit, M.J. Christmas, H. Clawson, J. Damas, F. Di Palma, M. Diekhans, M.X. Dong, E. Eizirik, K. Fan, C. Fanter, N.M. Foley, K. Forsberg-Nilsson, C.J. Garcia, J. Gatesy, S. Gazal, D.P. Genereux, L. Goodman, J. Grimshaw, M.K. Halsey, A.J. Harris, G. Hickey, M. Hiller, A.G. Hindle, R.M. Hubley, G.M. Hughes, J. Johnson, D. Juan, I.M. Kaplow, E.K. Karlsson, K.C. Keough, B. Kirilenko, K.P. Koepfli, J.M. Korstian, A. Kowalczyk, S.V. Kozyrev, A.J. Lawler, C. Lawless, T. Lehmann, D.L. Levesque, H.A. Lewin, X. Li, A. Lind, K. Lindblad-Toh, A. Mackay-Smith, V.D. Marinescu, T. Marques-Bonet, V.C. Mason, J.R.S. Meadows, W.K. Meyer, J.E. Moore, L.R. Moreira, D.D. Moreno-Santillan, K.M. Morrill, G. Muntane, W.J. Murphy, A. Navarro, M. Nweeia, S. Ortmann, A. Osmanski, B. Paten, N.S. Paulat, A.R. Pfenning, B.N. Phan, K.S. Pollard, H.E. Pratt, D.A. Ray, S.K. Reilly, J.R. Rosen, I. Ruf, L. Ryan, O.A. Ryder, P.C. Sabeti, D.E. Schaffer, A. Serres, B. Shapiro, A.F.A. Smit, M. Springer, C. Srinivasan, C. Steiner, J. M. Storer, K. A. M., P.F. Sullivan, E. Sullivan, M.A. Sundstrom, R. Supple, E. Swofford, J. Teeling, A. Turner-Maier, F. Valenzuela, Wagner, O. Wallerman, C. Wang, J. Wang, Z. Weng, A. P. Wilder, M. E. Wirthlin, J. R. Xue, X. Zhang. Leveraging base-pair mammalian constraint to understand genetic variation and human disease. Science. 380, 937 (2023) P.F. Sullivan, J.R.S. Meadows, S. Gazal, B.N. Phan, X. Li, D.P. Genereux, M.X. Dong, M. Bianchi, G. Andrews, S. Sakthikumar, J. Nordin, A. Roy, M.J. Christmas, V.D. Marinescu, C. Wang, O. Wallerman, J. Xue, S. Yao, Q. Sun, J. Szatkiewicz, J. Wen, L.M. Huckins, A. Lawler, K.C. Keough, Z. Zheng, J. Zeng, N.R. Wray, Y. Li, J. Johnson, J. Chen, s. Zoonomia Consortium section, B. Paten, S.K. Reilly, G.M. Hughes, Z. Weng, K.S. Pollard, A.R. Pfenning, K. Forsberg-Nilsson, E.K. Karlsson, K. Lindblad-Toh, G. Andrews, J.C. Armstrong, M. Bianchi, B.W. Birren, K.R. Bredemeyer, A.M. Breit, M.J. Christmas, H. Clawson, J. Damas, F. Di Palma, M. Diekhans, M.X. Dong, E. Eizirik, K. Fan, C. Fanter, N.M. Foley, K. Forsberg-Nilsson, C.J. Garcia, J. Gatesy, S. Gazal, D.P. Genereux, L. Goodman, J. Grimshaw, M.K. Halsey, A.J. Harris, G. Hickey, M. Hiller, A.G. Hindle, R.M. Hubley, G.M. Hughes, J. Johnson, D. Juan, I.M. Kaplow, E.K. Karlsson, K.C. Keough, B. Kirilenko, K.P. Koepfli, J.M. Korstian, A. Kowalczyk, S.V. Kozyrev, A.J. Lawler, C. Lawless, T. Lehmann, D.L. Levesque, H.A. Lewin, X. Li, A. Lind, K. Lindblad-Toh, A. Mackay-Smith, V.D. Marinescu, T. Marques-Bonet, V.C. Mason, J.R.S. Meadows, W.K. Meyer, J.E. Moore, L.R. Moreira, D.D. Moreno-Santillan, K.M. Morrill, G. Muntane, W.J. Murphy, A. Navarro, M. Nweeia, S. Ortmann, A. Osmanski, B. Paten, N.S. Paulat, A.R. Pfenning, B.N. Phan, K.S. Pollard, H.E. Pratt, D.A. Ray, S.K. Reilly, J.R. Rosen, I. Ruf, L. Ryan, O.A. Ryder, P.C. Sabeti, D.E. Schaffer, A. Serres, B. Shapiro, A.F.A. Smit, M. Springer, C. Srinivasan, C. Steiner, J. M. Storer, K. A. M., P.F. Sullivan, E. Sullivan, M.A. Sundstrom, R. Supple, E. Swofford, J. Teeling, A. Turner-Maier, F. Valenzuela, Wagner, O. Wallerman, C. Wang, J. Wang, Z. Weng, A. P. Wilder, M. E. Wirthlin, J. R. Xue, X. Zhang. Leveraging base-pair mammalian constraint to understand genetic variation and human disease. Science. 380, 937 (2023)

go back to reference C.V. Dang, E.P. Reddy, K.M. Shokat, L. Soucek, Drugging the ‘undruggable’ cancer targets. Nat. Rev. Cancer 17, 502–508 (2017)PubMedPubMedCentralCrossRef C.V. Dang, E.P. Reddy, K.M. Shokat, L. Soucek, Drugging the ‘undruggable’ cancer targets. Nat. Rev. Cancer 17, 502–508 (2017)PubMedPubMedCentralCrossRef